Search Results 271-280 of 16666 for anti-TNF drugs

1. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z ... OR has not had biologic therapy (TNF antagonists or vedolizumab) ... anti-tumor necrosis factors (TNFs) for at least 8 weeks.

2. Puberty blockers for transgender and gender-diverse youth - Mayo Clinic

   The medicines most often used for this purpose are called gonadotropin-releasing hormone (GnRH) analogues. Here's a summary of their possible benefits, side ...

3. Drugs and Supplements that Start with B - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “B” to learn about drug side effects, proper use and ...

4. Ustekinumab-srlf (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Antibiotics: Are you misusing them? - Mayo Clinic

   ... drugs. This can lessen the growth of antibiotic resistance. What causes antibiotic resistance? Bacteria resist a drug when the bacteria change in some way.

6. Drugs and Supplements that Start with C - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “C” to learn about drug side effects, proper use and ...

7. Ustekinumab-ttwe (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Anti-Aging Archives - Mayo Clinic News Network

   Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and ...

9. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Subject who received IV anti-infectives within 35 days prior to ...

10. Clinical trials - Oncology (Medical)

    However, the use of anti-inflammatory agents in ... Diet rich in trans-fat and sugar has been shown to increase pro-inflammatory cytokines IL-6 and TNFα ...